Financials
- Market Capitalization 511.89 M
- Employee 353
- Founded 2012
- CEO David Moatazedi
- Website www.evolus.com
- Headquarter Delaware, United States
- FIGI BBG005CX4HK8
- Industry İlaç Üreticileri - Özel ve Eşdeğer
Toplam gelir
Net kar
Temel hisse başına kazanç (Temel EPS)
Toplam borç
Serbest nakit akışı
Nakit ve eşdeğerleri
Fiyat/kazanç oranı
-8.31
Fiyat/satışlar oranı
1.44
Related tickers
| # | Ad | Fiyat | 24s % | 7g % | 1A % | 1Y % | Piyasa Değeri | Son 7 Gün | |
|---|---|---|---|---|---|---|---|---|---|
| 2715 | IRWD Ironwood Pharmaceuticals, Inc. - Class A Common Stock | 3.76 USD | -1.57% | +3.30% | -8.29% | +154.05% | 621.30 M USD | ||
| 2732 | AQST Aquestive Therapeutics, Inc. - Common Stock | 4.81 USD | +0.63% | +4.11% | +2.34% | -27.78% | 603.71 M USD | ||
| 2854 | TLRY Tilray Brands, Inc. - Common Stock | 3.36 USD | -5.08% | -10.16% | -15.79% | +104.88% | 496.57 M USD | ||
| 2875 | EVO Evotec SE - American Depositary Shares each representing 1/2 of | 1.37 USD | -10.46% | -20.81% | -18.45% | -67.92% | 487.11 M USD |